The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

This July Alfred Chin, fourth year student in the Tri-Institutional MD-PhD Program, won the grand prize of 20,000€ at the 2022 Merck Innovation Cup.The Merck Innovation Cup is an annual competition open to PhD students/postdocs from all over the world to develop an innovative project plan. This year, 42 people (7 teams of 6) were invited to Darmstadt, Germany out of 3580 applicants.
Nicolas Blobel, fifth year student in the Tri-Institutional MD-PhD program has received an F30 Research Award from the National Institute of Health. This award will support Mr.